Skip to main content
Glama

Data Iledefrance

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Despite strong annotations (readOnlyHint, idempotentHint, openWorldHint, destructiveHint false), the description adds substantial behavioral detail: it cascades through multiple lookup endpoints, degrades gracefully when GLEIF/OpenFIGI are unavailable, returns figi_candidates when matches are ambiguous, and explicitly lists unresolved identifiers rather than omitting them. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is thorough but overlong and dense, especially the long parenthetical about the company identity spine. It is front-loaded with useful examples and 'Use FIRST', and it is organized under SUPPORTED TYPES, but many details could be trimmed or bulleted for readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return behavior, and it does so well: it names the returned identifiers (CIK, ticker, company_name, LEI, FIGI, RxCUI), explains unresolved fields and figi_candidates, and covers failure/degradation modes. An agent has enough context to invoke the tool and interpret its results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers both parameters, so the baseline is 3, but the description adds far more: concrete examples (AAPL, CIK, ISIN, 'ozempic', 'metformin'), the distinction between issuer and security name for bonds, and the explicit warning to pass only the entity name. This materially improves the agent's chance of passing the correct value.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user-phrase examples and a clear verb+resource statement: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It also distinguishes the tool's scope from siblings by explaining it produces IDs for other tools, not profiles or comparisons.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID.' It also elaborates on supported types and edge cases, but it does not explicitly name alternatives like entity_profile or compare_entities or state when to prefer them, so it stops short of full when-not guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Data Iledefrance toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Many tools have overlapping purposes, e.g., multiple ask/tools for querying (ask_pipeworx, ask_pipeworx_grounded, deep_research) and multiple company analysis tools (entity_profile, compare_entities, recent_changes). The prediction market tools (bet_research, polymarket_arbitrage, etc.) further blur distinctions. Agents would frequently select the wrong tool.

Naming Consistency2/5

Naming conventions are inconsistent: snake_case (ask_pipeworx, dataset_info), camelCase (ai_visibility_check, scan_competitor_ai_presence), and phrases (pipeworx_feedback, polymarket_arbitrage). No pattern emerges, making tool discovery harder.

Tool Count2/5

33 tools is excessive for a server ostensibly about Île-de-France Open Data. Only 3 tools (dataset_info, query, search_datasets) relate to that domain, while the rest are a general-purpose data agent with many disjoint capabilities. The count feels bloated and unfocused.

Completeness2/5

For the declared purpose (Île-de-France data), the tool set is missing CRUD operations (no create/update/delete). For the actual general data use, there are gaps like missing person entity resolution, data visualization, and file handling. The deep_research tool requires an account, creating a barrier.

Resources